首页> 外文期刊>Malaria Journal >Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study
【24h】

Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study

机译:社区卫生工作者提供的蒿甲醚-荧光黄素在坦桑尼亚农村地区五岁以下并发疟疾的未成年儿童中的有效性:一项开放性前瞻性研究

获取原文
           

摘要

Background Home-management of malaria (HMM) strategy improves early access of anti-malarial medicines to high-risk groups in remote areas of sub-Saharan Africa. However, limited data are available on the effectiveness of using artemisinin-based combination therapy (ACT) within the HMM strategy. The aim of this study was to assess the effectiveness of artemether-lumefantrine (AL), presently the most favoured ACT in Africa, in under-five children with uncomplicated Plasmodium falciparum malaria in Tanzania, when provided by community health workers (CHWs) and administered unsupervised by parents or guardians at home. Methods An open label, single arm prospective study was conducted in two rural villages with high malaria transmission in Kibaha District, Tanzania. Children presenting to CHWs with uncomplicated fever and a positive rapid malaria diagnostic test (RDT) were provisionally enrolled and provided AL for unsupervised treatment at home. Patients with microscopy confirmed P. falciparum parasitaemia were definitely enrolled and reviewed weekly by the CHWs during 42 days. Primary outcome measure was PCR corrected parasitological cure rate by day 42, as estimated by Kaplan-Meier survival analysis. This trial is registered with ClinicalTrials.gov, number NCT00454961. Results A total of 244 febrile children were enrolled between March-August 2007. Two patients were lost to follow up on day 14, and one patient withdrew consent on day 21. Some 141/241 (58.5%) patients had recurrent infection during follow-up, of whom 14 had recrudescence. The PCR corrected cure rate by day 42 was 93.0% (95% CI 88.3%-95.9%). The median lumefantrine concentration was statistically significantly lower in patients with recrudescence (97 ng/mL [IQR 0-234]; n = 10) compared with reinfections (205 ng/mL [114-390]; n = 92), or no parasite reappearance (217 [121-374] ng/mL; n = 70; p ≤ 0.046). Conclusions Provision of AL by CHWs for unsupervised malaria treatment at home was highly effective, which provides evidence base for scaling-up implementation of HMM with AL in Tanzania.
机译:背景疟疾家庭管理(HMM)策略改善了撒哈拉以南非洲偏远地区高风险人群的抗疟疾药物的早期使用。但是,在HMM策略中使用基于青蒿素的联合疗法(ACT)的有效性方面的数据有限。这项研究的目的是评估由社区卫生工作者(CHW)提供并管理的,目前在非洲最受青睐的蒿甲醚-卢美他汀(AL)在坦桑尼亚5岁以下并发恶性疟原虫疟疾的5岁以下儿童中的有效性。不受父母或监护人在家的监督。方法在坦桑尼亚基巴哈地区的两个疟疾传播高的乡村进行了开放标签的单臂前瞻性研究。临时招募了患有CHW的儿童,包括单纯性发烧和快速疟疾诊断测试(RDT)阳性,并为AL提供在家中无监督治疗的条件。经镜检证实为恶性疟原虫寄生虫血症的患者肯定会在42天内由CHW每周进行登记和检查。主要结果指标是通过卡普兰-迈耶(Kaplan-Meier)生存分析评估的第42天,PCR校正的寄生虫治愈率。该试验已在ClinicalTrials.gov上注册,编号为NCT00454961。结果2007年3月至8月之间共招募了244名发热儿童。在第14天失去了两名患者的随访,在第21天撤消了一名患者的同意。在随访期间,约有141/241(58.5%)的患者反复感染。最多,其中14例复发。经过PCR校正的第42天治愈率为93.0%(95%CI 88.3%-95.9%)。与再感染(205 ng / mL [114-390]; n = 92)或无寄生虫相比,复发性患者(97 ng / mL [IQR 0-234]; n = 10)的lumantantrine浓度中位数显着降低重现性(217 [121-374] ng / mL; n = 70; p≤0.046)。结论CHW为在家中无监督的疟疾治疗提供AL是非常有效的,这为在坦桑尼亚扩大HMM与AL的实施提供了依据。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号